Andy Lewin

Chief Commercial Officer Pluri CDMO at Pluristem Therapeutics

Andy Lewin is currently serving as the Chief Commercial Officer at Pluri. Previously, Andy held various leadership positions in companies such as Ascend, SSNAP, Oxford Biomedica, AGC Biologics, NextPharma, OctoPlus, BioOutsource, SynCo Bio Partners, and Cobra Biomanufacturing. Andy's background includes a BA in Biochemistry from the University of Oxford.

Links

Previous companies

Ascend Gene & Cell Therapies logo
Oxford BioMedica logo
AGC Biologics logo

Org chart